Oak Associates Ltd. OH Makes New Investment in DaVita Inc. $DVA

Key Points

• Oak Associates Ltd. OH has purchased a new stake in DaVita Inc. valued at approximately $1.21 million, acquiring 7,919 shares in the first quarter.
• Over 90% of DaVita's stock is held by institutional investors and hedge funds, indicating strong institutional interest in the company.
• DaVita reported earnings of $2.95 per share for the last quarter, surpassing analyst expectations, and has set its FY 2025 guidance between 10.200-11.300 EPS.

Oak Associates Ltd. OH bought a new position in DaVita Inc. (NYSE:DVA - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 7,919 shares of the company's stock, valued at approximately $1,211,000.

A number of other institutional investors also recently bought and sold shares of DVA. Iron Triangle Partners LP bought a new position in DaVita in the 4th quarter worth $38,946,000. GAMMA Investing LLC raised its holdings in DaVita by 14,695.8% in the 1st quarter. GAMMA Investing LLC now owns 234,809 shares of the company's stock worth $35,919,000 after purchasing an additional 233,222 shares during the period. Northern Trust Corp raised its holdings in DaVita by 20.2% during the first quarter. Northern Trust Corp now owns 890,632 shares of the company's stock valued at $136,240,000 after acquiring an additional 149,858 shares during the period. Nuveen LLC bought a new stake in DaVita during the first quarter valued at about $20,218,000. Finally, Rovin Capital UT ADV bought a new stake in DaVita during the first quarter valued at about $18,442,000. 90.12% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on DVA shares. Barclays decreased their price target on DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Truist Financial set a $148.00 price target on DaVita in a report on Friday, August 8th. Finally, Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a report on Friday, August 22nd. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $164.00.

Insider Buying and Selling

In related news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider owned 26,038 shares in the company, valued at approximately $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.50% of the company's stock.

DaVita Trading Down 1.5%

DVA traded down $2.12 on Tuesday, hitting $135.65. The company had a trading volume of 241,065 shares, compared to its average volume of 852,499. The company has a market cap of $9.70 billion, a PE ratio of 13.35, a PEG ratio of 0.99 and a beta of 1.13. DaVita Inc. has a 12-month low of $126.07 and a 12-month high of $179.60. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. The business's fifty day simple moving average is $139.76 and its 200 day simple moving average is $142.29.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, topping the consensus estimate of $2.70 by $0.25. The company had revenue of $3.38 billion during the quarter, compared to analyst estimates of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm's revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the business posted $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Equities research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.